Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-16

FDA Approved: DECITABINE — Original Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved BluePoint Laboratories’ original application for decitabine as a generic injectable, establishing a generic version of the cancer drug. The app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)

Snippet

ORIG AP for DECITABINE (DECITABINE)